220 related articles for article (PubMed ID: 26374216)
1. Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland.
Marti A
Adv Exp Med Biol; 2015; 871():131-45. PubMed ID: 26374216
[TBL] [Abstract][Full Text] [Related]
2. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
Renner M; Anliker B; Sanzenbacher R; Schuele S
Adv Exp Med Biol; 2015; 871():87-101. PubMed ID: 26374214
[TBL] [Abstract][Full Text] [Related]
4. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea.
Choi M; Han E; Lee S; Kim T; Shin W
Adv Exp Med Biol; 2015; 871():163-79. PubMed ID: 26374218
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Cell and Gene Therapy Medicinal Products in Taiwan.
Lin YC; Wang PY; Tsai SC; Lin CL; Tai HY; Lo CF; Wu SI; Chiang YM; Liu LL
Adv Exp Med Biol; 2015; 871():181-94. PubMed ID: 26374219
[TBL] [Abstract][Full Text] [Related]
6. Regulatory Oversight of Cell- and Tissue-Based Therapeutic Products and Gene Therapy Products in Singapore.
Goh CW; Kellathur SN; Ong LL; Wu X
Adv Exp Med Biol; 2015; 871():195-212. PubMed ID: 26374220
[TBL] [Abstract][Full Text] [Related]
7. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
Lucas-Samuel S; Ferry N; Trouvin JH
Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
[TBL] [Abstract][Full Text] [Related]
8. Regulatory Frameworks for Gene and Cell Therapies in Japan.
Maeda D; Yamaguchi T; Ishizuka T; Hirata M; Takekita K; Sato D
Adv Exp Med Biol; 2015; 871():147-62. PubMed ID: 26374217
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Oversight of Cell and Gene Therapy Products in Canada.
Ridgway A; Agbanyo F; Wang J; Rosu-Myles M
Adv Exp Med Biol; 2015; 871():49-71. PubMed ID: 26374212
[TBL] [Abstract][Full Text] [Related]
10. The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built.
de Freitas DR
Adv Exp Med Biol; 2015; 871():213-9. PubMed ID: 26374221
[TBL] [Abstract][Full Text] [Related]
11. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
[TBL] [Abstract][Full Text] [Related]
12. The Regulation of Cell Therapy and Gene Therapy Products in Switzerland.
Bukovac PK; Hauser M; Lottaz D; Marti A; Schmitt I; Schochat T
Adv Exp Med Biol; 2023; 1430():41-58. PubMed ID: 37526841
[TBL] [Abstract][Full Text] [Related]
13. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
[TBL] [Abstract][Full Text] [Related]
14. A few ethical issues in translational research for gene and cell therapy.
Riva L; Petrini C
J Transl Med; 2019 Nov; 17(1):395. PubMed ID: 31779636
[TBL] [Abstract][Full Text] [Related]
15. Preface.
Galli MC
Adv Exp Med Biol; 2015; 871():v-vi. PubMed ID: 26677465
[No Abstract] [Full Text] [Related]
16. [European Marketing Authorisation: a long process. Experiences of small biotech companies with the ATMP regulation].
Buljovčić Z
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):831-8. PubMed ID: 21698536
[TBL] [Abstract][Full Text] [Related]
17. The European hospital exemption clause-new option for gene therapy?
Buchholz CJ; Sanzenbacher R; Schüle S
Hum Gene Ther; 2012 Jan; 23(1):7-12. PubMed ID: 22247961
[TBL] [Abstract][Full Text] [Related]
18. [Scientific advice by the nationally competent authority and by the EMEA on the conduct of clinical trials].
Dejas-Eckertz P; Schäffner G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):423-8. PubMed ID: 15830253
[TBL] [Abstract][Full Text] [Related]
19. New Japanese Regulatory Frameworks for Clinical Research and Marketing Authorization of Gene Therapy and Cellular Therapy Products.
Nagai S; Ozawa K
Curr Gene Ther; 2017; 17(1):17-28. PubMed ID: 28382858
[TBL] [Abstract][Full Text] [Related]
20. [Chapter 2. Clinical trials of advanced therapy medicinal products: which future for the European regulation].
Mahalatchimy A; De Grove-Valdeyron N
J Int Bioethique Ethique Sci; 2018 Jul; 29(2):35-51. PubMed ID: 30767446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
